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     Neonatal Abstinence Syndrome (NAS) in the infant are severe symptoms from opioid 
exposure in utero. These symptoms include: “central nervous system irritability, autonomic over-
reactivity, and gastrointestinal tract dysfunction” (Ko et al., 2016). The treatment for NAS can be 
a combination of drug therapy and non-pharmacological interventions, but a standardized 
treatment is lacking. A review of this literature aims to evaluate the available interventions that 
lead to decreased symptom severity, reduction of length of hospital stay, and a reduction in the 
use of drug therapy. As a result of the literature review, the nurse researcher supports the 
standardization of treatment and consistent use of non-pharmacological interventions by nurses 
to reduce withdrawal symptoms and as an adjunct to drug therapy. 
     This author recommends future research to be used to understand how consistently NICU 
nurses use non-pharmacological interventions. A question arose from the literature review: What 
are the most common non-pharmacological interventions used by NICU nurses as part of their 
institutional protocols? A pilot study with a mixed-methods approach will analyze how NICU 
nurses around the San Francisco (S.F.)Bay Area implement their facility’s NAS protocols. The 
nurse research will create a survey with open-ended and closed-ended questions. Furthermore, it 
will be analyzed using descriptive and content analysis. The study will intend to help nurses in 
three ways: practice effective and consistent non-pharmacological interventions, increase 
confidence in caring for newborns affected by NAS and be acquainted with protocols among Bay 
Area hospitals. 
Key Words: neonatal abstinence syndrome, morphine, cuddling, rooming-in, volunteer, and 
standardization.  
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     The use of prescription and illicit opioids in the United States (U.S.) is a growing burden on 
the healthcare system. Within a short period, “the number of women with opioid use disorder at 
labor and delivery more than quadrupled” (Ko, Haight, Tong, Bohm & Callaghan 2018 pg. 845). 
This rise of opioid use disorder has risen due to the excessive prescriptions and the challenges in 
accessing treatment to control pain (Ko et al.). The misuse of opioids during pregnancy leads to 
poor prenatal care, which results in preterm birth, low birth weight (LBW), neonatal abstinence 
syndrome (NAS), and respiratory depression (Feder, Letourneau, & Brook, 2018 pg.1). The 
characteristics of NAS can vary depending on the woman’s gestational age and other factors that 
can increase the severity of symptoms.  
Problem Statement 
   Opioid use during pregnancy can have detrimental effects, making this topic valuable to 
nursing practice. The rising incidence of NAS has prompted many healthcare professionals to 
develop different care methods for the newborn. Nurses are at the forefront of care for infants 
with NAS. Nurses need to know what other treatments are available for their patients. They also 
need to understand how to optimize outcomes for neonates with NAS.  
Problem Question 
     This thesis aims to answer these questions: How do pharmacological and non-
pharmacological interventions affect newborns diagnosed with neonatal abstinence syndrome? 
What are the best practices to treat NAS? This literature review will evaluate care and current 
practices that have shown beneficial outcomes for the newborn.  
 
 






     Neonatal Abstinence Syndrome in the neonate manifests as withdrawal symptoms from the 
mother’s use of opioids during pregnancy. A review of the literature will help to understand the 
treatment approaches for NAS. In this paper, the nurse researcher has reviewed six primary 
articles to analyze. The purpose of the review is to evaluate neonatal abstinence syndrome 
practices that lead to beneficial outcomes for the infant. This literature review was organized 
under two headings: management of treatment and types of treatment. The investigation 
produced many articles; therefore, the headings were subdivided into subheadings: assessment 
tool, predictive factors, standardization of treatments, cuddling, drug therapy, and rooming-in. 
The articles reviewed were located from Dominican University Archbishop Alemany Library 
database: CINAHL and PubMed from the years ranging from 2000-2021. An attached literature 
review table is added at the end of the paper. (Appendix A) 
 
MANAGEMENT OF TREATMENT 
Assessment Tool 
     The first step of the nursing process is an assessment which forms the basis of the care plan. 
The traditional Finnegan Neonatal Abstinence Scoring Systems (FNASS) was developed in the 
1970s. The infants symptoms are assessed which then a score is given and possibly 
pharmacological management. Healthcare providers widely accept the FNASS tool as the gold 
standard for evaluating NAS symptoms.  
     In a study conducted by Grossman, Lipshaw, Osborn, & Berkwitt (2018), a new tool was 
developed to assess infants. This new tool will aim to evaluate the withdrawal symptoms and 




decrease the use of pharmacological treatment. The researchers of this study believed that using 
the FNASS tool commonly leads to drug therapy. 
      The American Academy of Pediatrics (AAP) made recommendations based on research 
indicating the first line of defense for NAS is to focus on non-pharmacological interventions. 
Grossman et al. (2018) designed the Eat, Sleep, Console (ESC) as a non-pharmacologic 
intervention for NAS. This ESC tool would assess the newborn in a less intrusive way compared 
to the FNASS. The focus is to provide swaddling, on-demand feeding, and a low stimulation 
environment (Grossman et al., 2018).  
     The study design was a retrospective comparative study (quantitative) of 50 opioid-exposed 
infants. The procedure was conducted over 17 months in the well-newborn nursery. The 
symptoms were managed by using the ESC approach while at the same time gathering FNASS 
scores every 4 hours. The FNASS scores "were not used to guide medical decision making 
regarding the initiation of pharmacological treatment" (Grossman et al., 2018 p. 2).  
     The ESC approach asked three critical questions: Is the infant eating more than an ounce at 
each feeding?  Can the infant sleep one hour or more? And can the infant be consoled within 10 
minutes? If these answers were all "yes," then the infant was considered stable, and no further 
interventions were necessary. If one of these questions was a "no," interventions were strongly 
recommended: feeding on demand; swaddling and holding; low stimulation environment, and 
parental presence.  
     The study results revealed that only six infants (12%) were treated with morphine using the 
ESC approach, in contrast to 31 infants (62%) treated with morphine using the FNASS approach.  
Overall this innovative approach reduced the use of morphine in infants and successfully reduced 
the average length of stay (LOS ) in the hospital without any severe outcomes or readmissions.  




     The study had some limitations, including the inability to randomly assign patients into the 
FNASS group or the ESC group, causing the failure to compare the approaches’. Scoring for 
FNASS by different nurses was problematic, as each nurse has a different perspective on each 
infant's sign and symptoms.  
     The study proved that assessing infants with NAS by meeting the physiological needs of the 
newborn, instead of waiting for symptoms to manifest, is a more beneficial approach. Hospitals 
can lead the way by implementing this new assessment approach, leading to a guide for safe 
treatment and new protocols for infants with NAS.  
 
Predictive Factors  
     Since 1972, methadone, known as a fundamental treatment for opioid drug dependence, has 
been used during pregnancy. In the surge of the opioid crisis, the United States approved 
buprenorphine, a maintenance medication, to treat opioid addiction. In the U.S, both methadone 
and buprenorphine are considered safe drugs to use to treat opioid dependence in pregnancy.  
     In a study conducted by Kaltenbach et al. (2012), Predicting Treatment for Neonatal 
Abstinence Syndrome in Infants Born to Women Maintained on Opioid Agonist Medication, the 
objective was to analyze the factors that had the potential to increase the severity of NAS while 
receiving methadone or buprenorphine to treat opioid addiction.  
     The study design was a double-blind, double-dummy, flexible dosing, randomized clinical 
trial. The factors used to identify severity included: maternal weight at delivery, estimated 
gestational age, infant birth weight, delivery type, maternal nicotine use, days of maternal study 
medication received, and psychotropic medication during pregnancy.  




     During the clinical trials, all mothers received thorough treatment for substance abuse and 
prenatal care. The participants included 131 infants, of which two became ineligible because of 
unexpected death and prematurity. The procedure to monitor the severity of NAS consisted of a 
nurse trained as an expert-rater. These nurses received extensive training every six months, and 
they were placed in all the medical sites. The expert-rater observed symptoms and scored the 
infant every four hours with a modified Finnegan scale. In participants treated for NAS (68 
infants), about 53% required medication (morphine). The predictive factors such as infant weight 
and nicotine use before birth increased the use of drug therapy treatment and consequently 
increasing LOS.  
     Kaltenbach et al. ( 2012) aimed to analyze the factors that increase NAS treatment severity 
while the mother is treated for opioid addiction. Researchers concluded that during the 41 
months of the clinical trial, specific variables could alter treatment for opioid dependence. A high 
infant birth weight increased the probability of requiring treatment. Previous studies showed a 
relationship between estimated gestational age and higher infant birth weight would increase 
NAS symptoms.  
     The total amount of morphine used to treat infants was linked with fewer maternal receipt of 
study medication, consequently increasing LOS (Kaltenbach et al. 2012). The maternal mother's 
exposure to nicotine (cigarettes smoked during the 24 hours before delivery) was a significant 
predictor in the infant's treatment of NAS and the dose of morphine to treat NAS. The NAS 
scores were higher in infants with mother's use of SSRIs (antidepressants), requiring more 
significant amounts of morphine.   
     There were some limitations in the study, such as not examining the role that illicit opioids 
have on the expression of NAS that would require medication. It was not determined how many 




newborns received breastfeeding, and it is unknown what role breastfeeding has on NAS. The 
study did not condense drug classes to make specific conclusions on the severity of NAS. Further 
research is needed to examine specific SSRIs and the severity of NAS development.  
     This study's strength was the training of expert-raters throughout the study's entirety, resulting 
in good management accuracy. This article is relevant for the guidance of treatment because it 
was able to identify factors that increased the severity of NAS. This study will help develop 
interventions during the prenatal period to educate mothers regarding the factors that can 
increase NAS's severity. Physicians and nurses can also plan with the mother to modify factors 
such as nicotine use, delivery type, and maternal weight.  
 
Standardization of Treatments 
During this opioid epidemic, it is helpful to put forward the need for standardizing treatment for 
NAS. Although The American Academy of Pediatrics advises institutions to implement 
standardization of treatment of NAS, “single-institution prospective studies are lacking regarding 
the success of this approach”(Burnette, Chernicky, & Towers, 2019. p. 3415). In a study by 
Burnette et al. (2019), researchers developed a strict NAS management protocol. The study's 
objective was to analyze infant responses and LOS of neonates treated for NAS after initiating a 
strictly standardized treatment protocol.                
     This study sample and design was a prospective cohort that collected neonatal outcome data 
before and after implementing a strict NAS morphine weaning treatment protocol. The 
participants were a total of 395 neonates treated for NAS during the study. The research was 
conducted over 30 months, with the principal outcome being the length of stay. 




     The results concluded that LOS before the institution of the protocol was 23.31 LOS days (on 
233 neonates), and after the initiation of protocol, 18.17 LOS days (on162 neonates). The 
difference was 5.14 LOS days less for neonates treated under the strict protocol. The 
management before the strict protocol was led by the neonatologist, who determined the weaning 
process. Once the strict protocol was initiated, the weaning process was driven by the Finnegan 
score. This established consistency in management from the start. Another change in the strict 
protocol involved the use of "PRN" for morphine. Before the change, newborns who were being 
treated with morphine and did not show improvement could have morphine increase. After 
initiation, morphine was given as needed, or "PRN" to reduce the number of incidents before an 
increase of morphine.  
    This study's limitations were that many of the subjects were primarily Caucasian, and results 
can vary from populations with a higher mix of African American or Hispanic races. There was 
some inconsistency with the opioid used by the mothers, the most common being buprenorphine, 
and others such as methadone or heroin, which can create inconsistencies with the expressions of 
NAS. Although drug screening was periodically done during gestation and delivery, there is no 
way of truly knowing the specific drugs or poly-substance or intermixing to interpret accurately. 
     The strength of this study is the collection of data that affected LOS and the large cohort 
study from the same hospital. Researchers successfully implemented a strict NAS treatment 
protocol that demonstrated a reduction in LOS. This study can guide hospitals to implement 








TYPES OF TREATMENTS 
Cuddling  
      The approach to initiate treatment for newborns is non-pharmacological. There is 
considerable data provided by research on the different pharmacologic interventions, but a basis 
is a non-pharmacological approach. "Common methods of non-pharmacological care include 
swaddling, positioning, quiet and dimly lit rooms, rooming-in, skin-to-skin contact, 
breastfeeding, and infant positioning" (Mangat, Schmölzer, & Kraft, 2019). In this review, the 
nurse researcher chose an original study that required a volunteer cuddler. The feasibility of 
implementing the program was later assessed by interviewing both nurses and volunteers. 
    In October 2015, a study program in Toronto, Canada, conducted by Hignell et al. (2019), was 
launched to analyze the effects of cuddling infants that required treatment for NAS. The purpose 
of this study was to assess the impact of cuddling infants cuddled by trained volunteers and the 
effects of LOS. Researchers collected from two groups: 14 infants in the control group and nine 
infants in the cuddling program.  
     The study was a mixed-method technique with retrospective data collection. The researchers 
used the control group to measure the practicality of implementing a cuddler program. Cuddling 
was introduced as a standard of care for all infants and gave infants the needed support when 
families could not be present.  
     A group of trained volunteers were assigned to identify the need for comfort and 
overstimulation. Volunteers cuddled the infants in the sitting or standing position while engaging 
them with singing, reading, or talking. Newborns who could not leave the incubator due to 
medical fragility were comforted by the volunteers holding them through the window of 
incubators. 




     The study's limitation was that it could not compare the types of opioid exposure between the 
two groups. There was also an inconsistency with the amount of cuddling time each infant 
received. There are significant gaps in research on specific supportive care, such as cuddling.  
     The study’s strength was that it produced a reduction in LOS for the intervention group by six 
days compared to the control group. Although the sample size was small, the study was 
conducted over two years, demonstrating the impact that cuddling has on LOS. 
     The implementation of this new program created data from actual experiences through 
volunteers, nurses, and family members. Cuddling was an overall positive outcome for the infant 
as supportive care, resulting in reduced drug therapy. Many hospitals implement a variety of 
supportive care before implementing drug therapy. Current treatments such as breastfeeding, 
swaddling, rooming-in, skin-to-skin, quiet and dim rooms, and soothing techniques can be 
implemented while cuddling the infant.     
Drug Therapy 
     There are various pharmacological treatments for NAS, but for this review, the nurse 
researcher chose the most common: methadone and morphine. In a Comparison of Safety and 
Efficacy of Methadone vs. Morphine for Treatment of Neonatal Abstinence Syndrome (Davis et 
al., 2018), the researcher's objective was to identify which medication was more effective in the 
treatment of NAS.  
     The sample population included 117 infants in a randomized, quantitative, double-blind, 
intention-to-treat clinical trial. Mothers treated for substance abuse qualified to have their infant 
be randomly treated with morphine or methadone for pain control. The FNASS was used for 
assessing the infants’ symptoms every four hours. The treatment protocol, which lasted 25 
months, implemented drug therapy if the infant scored eight or higher two consecutive times on 




the FNASS. A one-time score of 12 higher would also initiate drug therapy. Researchers 
randomly assigned methadone every 8-hours or morphine every 8-hours, with an additional 
placebo alternating every 4 hours between opioid treatment. The study team also implemented 
the use of phenobarbital if the infant did not respond to treatment after morphine had been 
increased.  Although, phenobarbital was not considered part of the study.  
     Once the infant obtained a lower Finnegan score (generally <8), weaning from methadone or 
morphine was initiated by 10% every 12-48 hours. Once the infants' dosage reached 20% of the 
initial dose, treatment was stopped, and they were observed for 48 hours before discharge. 
     The researchers acknowledged that they did not meet the recruitment goal for three reasons. 
First, there was a 14-month delay in the study due to the development of the protocol. Secondly,  
mothers declined to enroll infants because they were also treated with methadone for maternal 
opioid addiction. Lastly, many sites began to implement non-pharmacological interventions, 
which reduced pharmacological treatment. 
     The strengths of this study include a multisite comparison and assessing quickly and control 
signs of NAS. This study showed that the use of methadone was more effective in decreasing the 
LOS and the length of treatment (LOT) compared to morphine. Currently, the FDA only makes 
recommendations to treat opioid dependence for pregnant mothers and not for neonates. Current 
drug therapies for neonates with NAS are essential for nurses to understand the outcomes and 
benefits.   
Rooming-In 
     Nursing interventions are the actions and treatments that nurses carry to support patients in 
meeting their set goals. A type of non-pharmacological intervention for NAS is the rooming-in 
approach, intended to keep the newborn with their mothers during the withdrawal stage. Cree, 




Jairath, & May (2019), researchers of A Hospital-Level Intervention to Improve Outcomes of 
Opioid Exposed Newborns, worked on a quality improvement project for a single site at 
Wellspan Health York Hospital. The study aims to determine if non-pharmacological strategies, 
such as the rooming-in approach, effectively care for the infants at risk of developing NAS and if 
this approach will reduce LOS and drug therapy use. Rooming-in allows the newborn to stay 
with the mothers in the hospital room throughout the initial hospitalization. They are then 
provided a private room on the pediatric floor for continued care and non-separation of mother 
and newborn while monitoring for NAS.  
     The sample size for this study included 88 infants that met eligibility requirements for 
inclusion in the study. The study's design and methods were a retrospective chart review that 
compared 48 infants in the control group exposed to methadone and buprenorphine in utero 
before implementing the rooming-in approach. Researchers then compared 40 infants in the 
intervention group with the same exposure in utero. In the intervention group, infants requiring 
drug therapy were transferred to the pediatric floor for further monitoring instead of the NICU.   
     Before implementing rooming-in, the admission rate for NAS in the NICU was 100%. After 
implementing rooming-in, the admission rate dropped to only 7.5%. The LOS decreased from 14 
days to 10.1 days post-implementation. There was also a significant finding in the total length of 
drug therapy, which fell from 15.98 days to 9.71 days post-implementation.  
     A single-center study and a small sample size present some limits to diverse populations and 
settings. There was also some exclusion of tobacco and other illicit drugs in data that previous 
studies have shown to increase the severity of NAS. Providers could not establish a process to 
begin weaning from drug therapy which created inconsistencies in care. Newborns that required 
drug therapy were admitted to the pediatric floor, but this became a challenge for mothers’ who 




were still inpatients. This challenge made it difficult for mothers’ to room with their babies.  
  Systematically identifying newborns at risk for NAS gave this study a strength. The staff's 
willingness to change their practice and manage NAS infants helped increase the study’s quality. 
Overall, rooming in the pediatric unit reduced LOS and NICU costs and allowed the mother to 
care for her newborn while receiving treatment. 
     Rooming-in addresses the issue of care settings in hospitals across the U.S. Caring for a 
newborn with NAS on a pediatric floor can be ideal. Still, rooming-in would be limited to 
specific hospitals. NICU nurses are responsible for caring for infants who need more acute care, 
and the study concluded that caring for infants in the inpatient pediatric floors can be safely 
managed. Research has shown that skin-to-skin decreases restlessness and respiratory distress 
and enhances engagement and breastfeeding while at the same time stimulating maternal-infant 
bonding (Ryan, G., Dooley, J., Gerber Finn, L., & Kelly, L. 2018). By implementing the 
rooming-in approach, infants can benefit from skin-to-skin contact ("kangaroo care") and 
breastfeeding (if not contraindicated). Further research is needed in hospitals that do not have 
pediatric units. 
DISCUSSION OF LITERATURE REVIEW 
     While analyzing the literature, I have seen that all the studies aim to reduce the severity of 
withdrawal symptoms in the newborn. Whether the treatment is in utero (for the mother) or after 
birth, researchers are working toward finding the most promising approach to treat neonates 
exposed to opiates. While pharmacological interventions are needed for severe symptoms, nurses 
and volunteers can implement non-pharmacological interventions to reduce symptom severity. 
Non-pharmacological interventions, such as feeding on demand, swaddling, and a low 
stimulation environment can all also decrease the length of stay and reduce the length of drug 





     Multi-site research is needed on the most effective non-pharmacological interventions that are 
used as treatment protocols. While searching for the volunteer cuddling interventions, I found a 
20-year gap in research that pointed to the need for complementary interventions. There is 
extensive research on drug therapy for both the mother and the infant, but non-pharmacological 
interventions are lacking. The American Academy of Pediatrics recommends the standardization 
of treatment for NAS, which has significantly improved neonatal response and decreased LOS 
(Burnette et al., 2019). Nurses are at the forefront of care; therefore they will benefit from 
understanding the initial interventions that can potentially decrease the severity of NAS.  
 
PROPOSAL FOR FURTHER STUDY 
Research Question 
     The purpose of this literature review was to evaluate both non-pharmacological and 
pharmacological interventions for newborns affected by neonatal abstinence syndrome and the 
best practices to care for them. A thorough review of the literature identified that many hospitals 
practice a variety of non-pharmacological interventions. I want to identify the specific techniques 
that are implemented among NICU nurses. The question I will aim to answer is: what are the 
most common non-pharmacological interventions that NICU nurses practice as part of their 
institutional protocols?  
Rationale For Study 
     The purpose of this study will help to identify similarities and differences in  non-
pharmacological interventions among NICU nurses in the Bay Area. Identifying these 
interventions will help nurses practice effectively and consistently while increasing confidence in 




caring for newborns affected by NAS. Hospitals can use this proposal to determine the 
consistency or inconsistencies and generate treatment protocols for the Bay Area. 
Theoretical Framework 
     The Theory of Comfort, developed by Katherine Kolcaba in 1990, is a framework that places 
comfort in the frontline of healthcare. According to Kolcaba, comfort is found in three states: 
relief, ease, and transcendence. By implementing the theory of comfort to this proposal, we can 
identify both pharmacological and non-pharmacological interventions for any patient. Through 
pain medications, patients can experience relief comfort. Ease of comfort is attained through the 
patients’ experience of contentment, for example, the easing of anxieties. Kolcaba explains 
transcendence as a state “in which patients can rise above their challenges” (2019, p. 6). In other 
words, the patient reaches a point where they established a sense of comfort that cannot be 
measured or understood.  
    Nurses can supply a variety of comfort measures for patients and families. Through the 
nursing process, we can provide interventions that will address symptoms and the whole person. 
The nursing process was designed to make changes according to the patient's condition. In the 
care of infants with NAS, nurses will monitor and assess these changes because symptoms of 
withdrawal do not immediately develop. At the same time, we can implement interventions for 
the infant to decrease the severity of withdrawals. Making our little patients comfortable in every 
way is the responsibility of nurses’. The theoretical framework of comfort will guide this 
research. 
Sample 
    The study population and eligibility criteria will only include registered nurses (RN’s ) 
working in the NICU around the Bay Area. We will use a snowball strategy to recruit nurses by 




sending out the survey through an online platform. The Likert survey will be created using 
Qualtrics, which can easily circulate online through social media for further recruitment. The 
sample size needed for this pilot study is 30-50 nurses or five per institution. A sample 
questionnaire is provided in Appendix B. 
Methods 
     I will use a cross-sectional mixed-methods approach to evaluate both quantitative and 
qualitative effects. The study will use a Likert survey with 25 questions with closed-ended and 
open-ended questions. Descriptive statistical analysis will interpret the quantitative data to find 
commonality and frequency. An analysis of variance (ANOVA) will be used to compare and a 
multiple regression will be applied to control for extraneous variables. For qualitative data, 
content analysis will be employed to establish the relationships between certain words, themes, 
or concepts. The mixed-methods design will produce a more thorough understanding of the 
practices of NICU nurses. 
Ethical Considerations 
     The ethical considerations for this study will include voluntary informed consent. The 
proposal will be reviewed by the institutional review board (IRB) of Dominican University. 
Nurses will also have the right to withdraw from the study at any time. Participants’ data will 
remain strictly confidential on a password-protected computer. The survey will impose a burden 
of time on the nurse of 15-20 minutes.  
 
           
 
 





    There are numerous studies on the effectiveness of drug therapy for infants that require 
treatment. The U.S. Federal Drug and Food Administration (FDA) has not approved a specific 
drug therapy for infants. Nevertheless, morphine is the most commonly used drug for NAS 
treatment when symptoms are not well controlled. Therefore, initiating non-pharmacological 
treatment is pivotal in treating NAS to reduce symptoms, reduce the length of hospital stay, and 
reduce the use of drug therapy.  
    The proposal for further research is intended for the specialized practices of NICU nurses. The 
intention will be to understand the most effective non-pharmacological interventions that are part 
of the hospital’s protocols. Novice nurses beginning in the NICU will learn many new skill-sets. 
This literature review will allow both novice and experienced nurses to gain knowledge about 
effective intervention so that they can implement new practices.  
     Preventing Neonatal Abstinence Syndrome (NAS) can only be accomplished by the mother 
refraining from opiates and other drugs during pregnancy. Substance abuse disorder is a global 
epidemic that requires a large-scale collaboration between public health officials, family 
agencies, and advocates. In the meantime, researchers and healthcare providers will continue to 
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APPENDIX A: LITERATURE REVIEW TABLE 1 
Authors/Citation Purpose/Objective of 
Study 
Sample - Population 
of interest, sample 
size 
Study Design Study Methods Major Finding(s) Strengths Limitations 
Kaltenbach, K., 
Holbrook, A. M., 
Coyle, M. G., Heil, S. 
H., Salisbury, A. L., 
Stine, S. M., . . . Jones, 
H. E. (2012). 
Predicting treatment 
for neonatal abstinence 
syndrome in infants 
born to women 








To  identify variety of 
factors that predict 
neonatal abstinence 
syndrome. 
131 newborn born to 
opioid dependent 
mothers 
 Randomized clinical 
trial; double blind, 
double dummy 
Infants were observed 
for 10 days to compare 
the benefits of 
methadone versus 
buprenorphine for the 
treatment of opioid 
dependence during 
pregnancy 
The study found 
gestations age, mothers 
weight at delivery, 
delivery type, infant 
weight, nicotine use, 
the use of SSRI’s and 
the days in which the 
mother participated 
with the study 
medications played a 
role in the severity of 
neonatal abstinence 
syndrome who were 
exposed to methadone 
or buprenorphine. 
This study was able to 
assess newborns who 
were exposed to 
methadone vs. 
buprenorphine. 
Unable to identify 
maternal use of illicit 
drugs. 
Unable to examine the 
role of breastfeeding or 
the days breasted, as 
some of the study 
samples chose to 
breastfeed. 
Unable to examine the 
variety of drugs 
prescribed to mothers 
limits the ability of 
conclusions. 
Davis, J. M., 
Shenberger, J., Terrin, 
N., Breeze, J. L., 
Hudak, M., Wachman, 
E. M., . . . Lester, B. 
(2018). Comparison of 
Safety and Efficacy of 
Methadone vs 
Morphine for 
Treatment of Neonatal 
Abstinence 
Syndrome. JAMA 
To compare the safety 
and benefits of 
methadone and 
morphine for neonatal 
abstinence syndrome 
117 Infants were 






Mother’s that had 
received 
buprenorphine, 
methadone or opioids 
qualified to have their 
infant to be randomly 
treated with morphine 
or methadone for pain 
control. Infants were 
assessed using the 
Finnegan Neonatal 
Abstinence Syndrome 
Methadone was found 
to be more effective 
than morphine as a 
pharmacologic 




with methadone had a 
shorter length of stay 
(14%) compared to 
morphine. 
This study offers 
evidence based 
implications for the 
pharmacological 
treatment of neonatal 
abstinence syndrome. 
Unable to meet 
recruitment goal 

















Grossman, M. R., 
Lipshaw, M. J., 
Osborn, R. R., & 
Berkwitt, A. K. (2018). 
A novel approach to 
assessing infants with 
neonatal abstinence 
syndrome. Hospital 




The development of a 
novel assessment 
approach and 
describing its effect on 
the management of 
infants with NAS. 
 
50 infants on the 
inpatient unit at the 
Yale new Haven 
Children’s Hospital 






The study methods 
compared two different 
approaches to opioid 
exposed infants: 
FNASSF and ESC 
approaches. The 
traditional method of 
the Finnegan Neonatal 
Abstinence Scoring 
(which uses a score of 
greater than 8 to 
initiate 
pharmacological 
treatment). The Eat, 
Sleep, Console (ESC) 
approach focused on 
the essential function 
of the newborns 
without interruptions. 
Using the new ESC 
approach decreased the 
use of Morphine to 
treat NAS, compared 
to using the FNASS 
approach. The new 
ESC approach was 
effective in managing 
infants with NAS while 
limiting pharmacologic 
treatment. 
Implementing a new 
approach, ESC, for the 
management of opioid 
exposed infants. 
Randomly assigned 
patients into FNASS 
and ESC groups which 
rendering the inability 
to compare the 
approaches to the 
length of stay. 
Reliability of Finnegan 
Scores among all the 
different nurses. 
Possibly readmission 
of discharged infants, 
however most NAS 




Hignell, A., Carlyle, 
K., Bishop, C., 
Murphy, M., 
Valenzano, T., Turner, 
S., & Sgro, M. (2019). 
The Infant Cuddler 
Study: Evaluating the 
effectiveness of 
volunteer cuddling in 
infants with neonatal 
abstinence syndrome. 
Paediatrics & Child 





To assess the 
practicality and the 
impact of trained 
volunteers cuddling 
program on the length 
of stay for infants born 
with NAS. 
 
Data was collected 
from 14 infants 
enrolled in the pilot 
study cuddling 
program 
A qualitative and 
quantitative study with 
a retrospective control 
group. 
Mixed methods. Pilot 
cohort study with 
retrospective control 




Length of stay was 
reduced by 6.36 days 
for infants in the pilot 
program and the 
volunteers reported a 
positive impact of 
cuddling program on 
infants, families, staff 
and volunteers alike 
Intentions of providing 
comfort to infants and 






Inability to provide 
data on the different 
opioid exposures 
between the two 
groups. 
Wide variability in the 
amount of cuddling 
time received by each 
infant. 
Burnette, T., 
Chernicky, L., & 
Towers, C. V. (2019). 




syndrome. The Journal 








To evaluate overall 
newborn response and 
length of stay (LOS) of 
neonates treated for 
NAS following the 
institution of a strict 
standardized treatment 
protocol. 
The sample population:  
A total 395 Neonates 
being treated for NAS 
A prospective cohort 
study by collecting 
data. 
Collecting neonatal 
outcome before and 
after the 
standardization of a 
strict NAS morphine 
weaning treatment 
protocol. 
The study found that 
by initiating a 
standardized NAS 
treatment protocol it 
can improve neonatal 
response and decrease 
length of stay. 
Prospective data 
collection 
Study population was 
primarily Caucasian 
and results can vary is 
compared with 
populations that have a 
higher mix of African 
American or Hispanic 
races. 
Most frequent drug 
seen was 
buprenorphine. 
Does not prove that the 
strict use of morphine 
weaning protocol used 
at the institution should 
be adopted. 




Cree, M., Jairath, P., & 
May, O. (2019). A 
hospital-level 
intervention to improve 
outcomes of opioid 
exposed 
newborns. Journal of 







in to care for newborn 
affected or at risk of 
NAS reduce length of 
stay and reduce the 
need for drug therapy 
70 infants exposed to 
methadone or 
buprenorphine in utero 
Retrospective chart 
review 
Charts were reviewed 
before implementation 
of intervention and  
after intervention 
Reduction of length of 




identification of infants 
born with NAS using 
the EHR 
 
A single center study 
Small sample size 
Exclusion of exposure 
of other substances. 
Hospital setting or 
layout to transition 




       










Years as NICU Nurse:_______ 
Are you currently working at a NICU Nurse? Yes / No 
If no, you are not working in a NICU, how many years has it been since you worked in 
that setting? ____________years. 
Directions: Please answer the following questions that most accurately reflect your 
opinions. 
1. In your opinion, does your place of employment successfully care for infants born with 
neonatal abstinence syndrome? 
0 [Strongly Disagree]   
1[Disagree]   
2[Neither Agree or Disagree]   
3[Agree]   
4[Strongly Disagree] 
 
2. Does your hospital regularly pre-screen mothers for opioid use? 
0 [Strongly Disagree]   
1[Disagree]   




2[Neither Agree or Disagree]   
3[Agree]   
4[Strongly Disagree] 
3. How often do you use the Eat, Sleep, Console (ESC) assessment tool? 
0 [Strongly Disagree]   
1[Disagree]   
2[Neither Agree or Disagree]   
3[Agree]   
4[Strongly Disagree] 
4. How often do you use the FNASS  or modified Finnegan Scale assessment tool? 
0 [Strongly Disagree]   
1[Disagree]   
2[Neither Agree or Disagree]   
3[Agree]   
4[Strongly Disagree] 
5. Does your hospital recruit volunteers to help with feeding, cuddling, or consoling infants 
with NAS in the NICU? 
0 [Strongly Disagree]   
1[Disagree]   
2[Neither Agree or Disagree]   
3[Agree]   
4[Strongly Disagree] 




6. Do you believe that having volunteers would be more effective in assisting you with the 
care of an infant with NAS? 
0 [Strongly Disagree]   
1[Disagree]   
2[Neither Agree or Disagree]   
3[Agree]  
4[Strongly Disagree] 
7. Do parents regularly participate in the care of infants being treated for NAS? 
0 [Strongly Disagree]   
1[Disagree]   
2[Neither Agree or Disagree]   
3[Agree]   
4[Strongly Disagree] 
8. If your hospital offers rooming-in for infants with NAS, can you describe the protocol for 
this procedure? Please explain.______________________________________________ 
9. If your hospital uses the ESC approach does it effectively control withdrawal symptoms? 
Please describe._________________________________________________________ 
10. If your hospital uses the FNASS tool does it effectively control withdrawal symptoms? 
Please describe.________________________________________________________ 
